Attralus
Attralus is a startup headquartered in Burlingame, United States, founded in 2019. It has raised at least $56.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Attralus has raised at least $56.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Attralus sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Burlingame
Related
- Innovation profile of Burlingame
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Attralus do?
Attralus is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Attralus raised?
At least $56.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Attralus based?
Attralus is headquartered in Burlingame, United States.
When was Attralus founded?
Attralus was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.